title: [ERCC1 mRNA expression levels and outcome of gastric cancer patients receiving oxaliplatin-based chemotherapy].
authors.forename: Jia
authors.initials: J
authors.lastname: Wei
authors.forename: Zheng-yun
authors.initials: ZY
authors.lastname: Zou
authors.forename: Xiao-ping
authors.initials: XP
authors.lastname: Qian
authors.forename: Li-feng
authors.initials: LF
authors.lastname: Wang
authors.forename: Li-xia
authors.initials: LX
authors.lastname: Yu
authors.forename: Bao-rui
authors.initials: BR
authors.lastname: Liu
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D004359:Drug Therapy, Combination; D004720:Endonucleases / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D000077150:Oxaliplatin; D012333:RNA, Messenger / Q000187:drug effects* / Q000378:metabolism; D013223:Statistics as Topic; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D009944:Organoplatinum Compounds; D012333:RNA, Messenger; D000077150:Oxaliplatin; C071447:ERCC1 protein, human; D004720:Endonucleases; D005472:Fluorouracil